Zobrazeno 1 - 10
of 72
pro vyhledávání: '"Michał M, Farkowski"'
Autor:
Łukasz Januszkiewicz, Sérgio Barra, Eloi Marijon, Rui Providencia, Carlo de Asmundis, Julian K R Chun, Michał M Farkowski, Giulio Conte, Serge Boveda
Publikováno v:
EP Europace. 25:1144-1151
Aims Information provided to patients prior to implantable cardioverter-defibrillator (ICD) insertion and their participation in the decision-making process are crucial for understanding ICD function and accepting this lifelong therapy. The aim of th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5d1253b72ae76a074402fcf0f2e9dfc1
https://doi.org/10.1093/europace/euac275
https://doi.org/10.1093/europace/euac275
Autor:
Michał M. Farkowski, Michał Karliński
Publikováno v:
In a good rythm. 3:8-11
Long-term cardiac rhythm monitoring using implantable cardiac monitors in patients with ischemic stroke has been described both in cardiac and neurological clinical practice guidelines. We present a case study describing the clinical decision-making
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::046b71f4ddf8a475a2b4b0988dd12d75
https://doi.org/10.5604/01.3001.0016.1825
https://doi.org/10.5604/01.3001.0016.1825
Autor:
Łukasz Januszkiewicz, Sérgio Barra, Rui Providencia, Julian K R Chun, Giulio Conte, Michał M Farkowski, Jose M Guerra, Eloi Marijon, Carlo de Asmundis, Serge Boveda
Aims The aim of this study was to identify potential regional disparities in characteristics of implantable cardioverter-defibrillator (ICD) recipients, patient perceptions and perspectives after implantation and level of information provided to pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7baabd390f1deca98d406a273d4f5086
https://doi.org/10.1093/europace/euad110
https://doi.org/10.1093/europace/euad110
A syncope in Brugada syndrome – to implant a cardioverter-defibrillator, a loop recorder or nothing?
Autor:
Michał M. Farkowski
Publikováno v:
In a good rythm. 2:13-15
Therapeutical decisions in case of a patient with Brugada syndrome and unexplained syncope are difficult and should be made after careful assessment of individual risk of sudden cardiac death and potential complications of cardiac electrotherapy. Thi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cbb09878560ed42bfd3d05c846d5541d
https://doi.org/10.5604/01.3001.0016.0697
https://doi.org/10.5604/01.3001.0016.0697
Autor:
Piotr Gardziejczyk, Rafał Dąbrowski, Michał M. Farkowski, Mariusz Pytkowski, Ilona Kowalik, Aleksander Maciąg, Anna Klisiewicz, Krzysztof Jaworski, Bohdan Firek, Karol Kołakowski
Publikováno v:
Cardiovasc Drugs Ther
Purpose To compare effectiveness of different treatments for atrial fibrillation (AF) patients who were scheduled for cardioversion (CV) or ablation (CA) presenting with left atrium appendage (LAA) thrombus despite chronic oral anticoagulation therap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74985a0d01d0166d0240d37f93209f4d
https://doi.org/10.1007/s10557-021-07278-9
https://doi.org/10.1007/s10557-021-07278-9
Publikováno v:
Kardiologia polska.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2353fef3a853bd993244874f99b4283a
https://pubmed.ncbi.nlm.nih.gov/36594535
https://pubmed.ncbi.nlm.nih.gov/36594535
Autor:
Michał M. Farkowski
Publikováno v:
In a good rythm. 4:11-13
Current ESC guidelines present several indications for catheter ablation as a first-line treatment of paroxysmal atrial fibrillation. Those indications reflect high effectiveness and safety of catheter ablation also in comparison to antiarrhythmic dr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a845ba45a86307dbc51164cdd799836b
https://doi.org/10.5604/01.3001.0015.8133
https://doi.org/10.5604/01.3001.0015.8133
Autor:
Michał M. Farkowski, Krzysztof Lach, Malwina Pietrzyk, Ewelina Baryla-Zapala, Małgorzata Gałązka-Sobotka, Iwona Kowalska-Bobko, Cezary Kępka, Tomasz Hryniewiecki
Publikováno v:
International Journal of Environmental Research and Public Health; Volume 19; Issue 14; Pages: 8855
Hospital-based health technology assessment (HB-HTA) is a scientific approach to inform decisions on investments in health technologies across multiple medical specialties at a hospital level. HB-HTA is not currently practiced in Poland. This study a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf164f1e390c9b93c4d924b332fee980
https://pubmed.ncbi.nlm.nih.gov/35886720
https://pubmed.ncbi.nlm.nih.gov/35886720
Autor:
Beata Ceynowa-Sielawko, Maciej T. Wybraniec, Aleksandra Topp-Zielińska, Aleksander Maciąg, Dawid Miśkowiec, Paweł Balsam, Maciej Wójcik, Wojciech Wróbel, Michał M. Farkowski, Edyta Ćwiek-Rębowska, Krzysztof Ozierański, Robert Błaszczyk, Karolina Bula, Tomasz Dembowski, Michał Peller, Bartosz Krzowski, Wojciech Wańha, Marek Koziński, Jarosław D. Kasprzak, Hanna Szwed, Katarzyna Mizia-Stec, Marek Szołkiewicz
Publikováno v:
International Journal of Environmental Research and Public Health; Volume 19; Issue 8; Pages: 4880
Pharmacological cardioversion (PCV) is commonly a primary option for termination of recent-onset atrial fibrillation (AF) in emergency departments (ED). This is a subanalysis of the CANT II study, evaluating the effectiveness and safety of antazoline
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9f9345fb9cf909f6f8367e06cb4c4eb
Autor:
Przemysław Mitkowski, Marcin Gułaj, Andrzej Przybylski, Maciej Kempa, Michał M. Farkowski, Maciej Sterliński
Publikováno v:
Kardiologia Polska. 78:488-492
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60cbea5a7f5f6f1b6a84365abb9b8e6b
https://doi.org/10.33963/kp.15338
https://doi.org/10.33963/kp.15338